KR20040086581A - A medicine bag - Google Patents

Abstract

PURPOSE: Provided is a medicine bag to allow a user visually to confirm the state of the medicines shielded by a light-shielding portion, such as how well the medicines are preserved and how properly the medicines are mixed, and to allow the mixed medicines to be appropriately administered to a patient. CONSTITUTION: The medicine bag(1) comprises a bag body(2), a cover sheet(52), and a requisitely-used portion. The bag body has a medicine storage chamber(4) that stores a medicine in such a way that the medicine is visually confirmed through a light-transmission portion(51). The bag body has a weak seal portion(4a,4b) that divides the medicine storage chamber into a plurality of division spaces(5,7). The sealing of the weak seal portion adjacent to a specific division space is removed by increasing the internal pressure of that division space. The cover sheet is peelably attached to the bag body. The requisitely-used portion is used in the process shortly before the medicine is administered. The cover sheet includes a light-shielding portion(52a) which shields from the light the medicine stored in one division space, and a continuously-formed portion(52b) which is continuously formed in the light-shielding portion.

Description

Pharmaceutical Bag {A MEDICINE BAG}

The present invention provides a medicine bag for use in a medical field or the like, and in detail, a chamber portion for dividing the inside of the bag body into a plurality of compartments, and by increasing the room pressure of a specific compartment, the state of the chamber portion adjacent to the compartment is released. It relates to the medicine bag which mixes and uses the chemical | medical agent accommodated in a predetermined compartment.

Some drugs may be used as a drug to be administered to a patient by intravenous injection. Some of these drugs may be unstable to deteriorate with time when mixed in advance. In the past, in the case of storing such unstable drugs, a plurality of compartments for individually accommodating the medicaments prior to mixing constituting the medicament are provided, and each compartment is communicated with each other so as to mix the medicaments contained in each compartment. It is common to use a configured medicine bag.

By the way, some drugs may deteriorate when exposed to light for a long time, and when such a light-modifying agent is accommodated in the compartment, the compartment may use a medicine bag coated by a light shielding layer portion such as an aluminum thin layer portion. .

The pharmaceutical bag having such a light shielding layer part is, for example, disclosed in European Patent No. 0639364A1 or Japanese Patent Registration No. 1107140, and has a liquid chamber and a light variability in which the body of the bag contains a liquid by a peelable chamber part. It is partitioned into a medicament room containing dry medicine. The inner wall constituting the drug storage chamber is composed of a transparent flexible sheet, and a coating having a light shielding layer portion made of an aluminum processed film or a colored film covering the inner wall so as to shield the drug in the inner wall can be peeled off from the bag body. Is attached.

In general, in the use of the medicine bag, the liquid compartment is pressurized by hand to pressurize the liquid compartment, and the liquid compartment is communicated with the chemical compartment by peeling the chamber part using the pressure of the liquid generated at this time. Mix drugs in each compartment. Next, the operation of hanging the hole provided in the bag main body by hanging it on the hanger of the bag stand is performed, and the remaining amount display unit (scale, etc.) provided in the bag main body to display the remaining amount of the mixed drug as described above, After confirming the total amount of the medicine, and finally, a tube or the like for injecting the medicine into the patient is connected to the port of the medicine bag so that the mixed medicine in the medicine bag is administered to the patient. On the other hand, in addition to the operation immediately before the series of administration, in order to administer the drug in an appropriate state, the coating is peeled off so as to visually confirm the mixed state or preservation state of the drug through the transparent flexible sheet.

However, in the case of using the medicine bag of EP 0639364A1, even though the necessity of the visual confirmation is called, for example, peeling of the coating is not performed according to the user's habit, or complicated. When the user forgets the peeling of the coating at the time, in such a case, as a result of a series of administration operations without visually confirming the drug in the drug storage chamber, the drug to be originally mixed is not mixed. There was a risk of administering to the patient as it is, or mixing the drug with the changed appearance to the patient.

The present invention has been made in view of the above-described problems, and by reliably performing peeling of the coating in the process of immediately prior to a series of administrations, the mixed state of the drug, the preservation state, and the like can be visually confirmed. It is an object to provide a medicine bag that can be appropriately administered.

It is an object of the present invention to provide a pharmaceutical bag without the problems in the prior art.

It is a front view which shows the chemical | medical agent bag which concerns on 1st Embodiment.

2 is a cross-sectional view taken along the line II-II of FIG. 1.

3 is a cross-sectional view taken along the line III-III of FIG. 1.

Fig. 4 is an enlarged cross-sectional view of the main portion showing the bonding state of the covering sheet portion.

5 is an enlarged cross-sectional view illustrating a connection state between an upper container and a lower container.

Fig. 6 is an enlarged cross-sectional view of the main portion showing the bonding state of the cover sheet portion of the chemical | medical agent bag which concerns on the modification of 1st Embodiment.

7 is a front view showing a medicine bag according to still another modification of the first embodiment.

It is a front view which shows the chemical | medical agent bag which concerns on 2nd Embodiment.

9 is a sectional view taken along line VII-VII.

10 is a sectional view taken along the line VII-VII of FIG. 8.

Fig. 11 is a schematic cross-sectional view showing a third embodiment of the present invention.

It is a front view which shows the chemical | medical agent bag which concerns on 4th Embodiment of this invention.

13 is a sectional view taken along the line XIII-XIII of FIG.

Fig. 14 is a schematic cross-sectional view showing a medicine bag according to a fifth embodiment of the present invention.

Fig. 15 is a partial cross-sectional schematic view of the medicine bag according to the sixth embodiment of the present invention.

It is a partial cross section figure which shows the chemical | medical agent bag which concerns on 7th Embodiment of this invention.

It is a front view which shows the chemical | medical agent bag which concerns on 8th Embodiment of this invention.

18 is a cross-sectional view taken along the line XVIII-XVIII of FIG. 17.

Fig. 19 is a cross-sectional view taken along the line VI-XIV of Fig. 1.

20 is a front view showing a ninth embodiment of the present invention.

It is a front view which shows the chemical | medical agent bag which concerns on the 10th embodiment of this invention.

It is a front view which shows the chemical | medical agent bag which concerns on 11th Embodiment of this invention.

Fig. 23 is a cross sectional view taken along the line XIII-XIII of Fig. 22.

24 is a partial cross-sectional schematic diagram showing a modification of the medicine bag of FIG. 23.

According to one aspect of the present invention, a medicine bag comprises a bag body and a coating sheet detachably attached to the medicine bag body. The bag body raises the room pressure of the medicine storage chamber for storing drugs, the chamber part for partitioning the medicine storage chamber into a plurality of compartments, and the compartment pressure in which the medicine can be visually identified through the light-transmitting portion provided at least in part. And sealing of the chamber section adjacent to the particular compartment being removed. The medicine bag also has an essential use part which is used just before administration of the medicine.

The covering sheet includes a speech portion spoken in the shielding portion for preventing the use of the shielding portion for shielding the medicine stored in the at least one compartment from the light from the light and the essential use portion with the covering sheet by covering the predetermined portion of the transmitting portion. .

<Best Mode for Carrying Out the Invention>

The above and other objects, features and features of the present invention will become more apparent upon reading the following detailed description in conjunction with the accompanying drawings.

Embodiment of this invention is described using drawing. The chemical | medical agent bag of this embodiment demonstrates mixing two types of chemical | medical agents (here, it uses in a wide concept including a solution, a diluent, etc.), with a chemical | medical agent of a photovariable powder, and a solution (solution), but mixing The chemical | medical agent made, its property, a kind, etc. are not limited to this. That is, the liquid to be mixed and the light-shielding agent may be contained in the medicine to be mixed, for example, a light-variable liquid and a powder or solid medicine or a liquid as a diluent may be mixed, or the medicine to be mixed is also 3 It may be more than a kind. Here, the light-shielding agent includes a light-variable agent that changes when exposed to light, as well as a drug that is covered by a light shielding sheet such as an aluminum sheet for the purpose of preventing oxidation, moisture absorption, and water evaporation.

As shown in FIGS. 1-3, the chemical | medical agent bag 1 which concerns on the 1st Embodiment of this invention is taken in the bag main body 2 of the substantially vertical rectangular shape when seen from the front, and a lower part of this bag main body 2. It is equipped with a prepared port (3).

The bag main body 2 has a drug storage chamber 4 that can accommodate a medicine in a state that can be visually confirmed through a light transmitting portion therein, and the medicine storage chamber 4 is a chamber portion 4a, 4b. It is partitioned into two compartments 5 and 7, up and down by). The upper compartment 5 can contain a photovariable solid drug (for example, hydrochloric acid hydrochloric acid), while the lower compartment 7 contains a solution for the solid drug (eg For example, physiological saline solution) can be accommodated. The bag main body 2 includes an upper container 6 constituting the upper compartment 5 and a lower container 8 constituting the lower compartment 7, and these accommodating containers 6 previously formed as separate bodies. (8) is connected in the state which can communicate with each compartment 5,7.

Moreover, the number of compartments, the arrangement | positioning form in the bag main body 2, etc. are not specifically limited, It sets suitably in consideration of the kind, the form, etc. of the chemical agent to mix.

The upper container 6 is a flexible container which has a substantially rectangular shape when viewed from the front, and is configured to not transmit moisture, oxygen and light in the upper compartment 5. The upper container 6 includes a rear seat 50 having a light shielding layer 70 and a front seat 51 disposed on the front surface of the rear seat 50. These rear seats 50 and front seats

The 51 is joined at the periphery by welding and formed into a bag shape, and the predetermined shape is formed in a state where both sheets 50 and 51 penetrate through the hole formation region at the center of the joint portion at the end. In Fig. 1, a hole 54 (hanger engaging portion) having a circular shape is provided.

Specifically, the rear seat 50 is composed of a laminated sheet including a light shielding layer 70 that blocks light and an innermost layer made of a thermoplastic resin that can be welded firmly to the front sheet 51 at the periphery. . In the first embodiment, as shown in FIG. 3, a welding layer 71 made of thermoplastic resin such as polyethylene, polypropylene, or a mixture thereof, and polyethylene terephthalate (PET) or nylon on which aluminum is deposited, in order from the innermost layer. Or the light shielding layer 70 which consists of aluminum foil, etc., and the reinforcement layer 72 which consists of PET, nylon, etc. are laminated | stacked, and is comprised. In addition, the light shielding layer 70 prevents the medicine contained in the upper compartment 5 from being exposed to light through the rear seat 50. Therefore, the upper compartment 5 is prevented through the rear sheet 50. I cannot see myself visually. In addition, in the first embodiment, the light shielding layer 70 is configured to not transmit moisture and oxygen.

The front sheet 51 is a laminated sheet including an innermost layer made of a thermoplastic resin that can be welded to the rear sheet 50 at the periphery thereof, and through the front sheet 51 in the upper compartment 5. It is composed of a transparent sheet (including a translucent and colored transparent sheet) so that it can be visually confirmed. In other words, the front sheet 51 corresponds to the light transmitting portion. In the first embodiment, as shown in Fig. 3, the welding layer 73 made of thermoplastic resin such as polyethylene, polypropylene, or a mixture thereof, and the like, PET, nylon or EVOH on which silica and alumina are deposited, in order from the innermost layer. (Ethylene vinyl alcohol copolymer) or the like, barrier layer 74 configured to not permeate moisture and oxygen, reinforcement layer 75 made of PET or nylon, etc., weak adhesion layer made of polyethylene, polypropylene, PET, etc. 76 is laminated | stacked and comprised. As for the welding layer 73 of this front seat 51, thermoplastic resin with high compatibility with the welding layer 71 of the said rear seat 50 is employ | adopted, and each sheet 50 and 51 is welded firmly. It is said that I can do it.

A concrete bonding structure between the rear seat 50 and the front seat 51 will be described. In the upper end and left and right edges of the upper container 6, the rear seat 50 and the front seat 51 are firmly joined by welding. On the other hand, in the lower end part of the upper container 6, the chamber sheet 40 is opened in the state which the lower end part protruded from the lower edge of each sheet 50 and 51, It is joined by weak welding via the chamber sheet 40 in the upper end part of the practical sheet 40 (refer FIG. 5).

That is, the chamber part 4a is formed in the lower end part of the upper container 6 using the chamber sheet 40, and this chamber part 4a has the upper and lower compartments 5 and 7 at least either one. It is comprised so that peeling may be carried out by raising the room pressure of (the real state is canceled). Specifically, the chamber sheet 40 is formed of a thermoplastic resin having low compatibility with the thermoplastic resins constituting the welding layers 71 and 73 of the rear seat 50 and the front seat 51. have. For example, when polyethylene synthetic resin is used as the welding layers 71 and 73, as the chamber sheet 40, polyethylene and resins which do not have compatibility with this, for example, polypropylene, etc. Mixtures are suitably employed. As the thermoplastic resin constituting the chamber sheet 40 as described above, the thermoplastic resin constituting the welding layers 7l and 73 has a low compatibility with the thermoplastic resin, and thus the chamber portion 4a as the welding portion is used. ) Can be peeled relatively easily.

In addition, the upper container 6, the upper compartment in the front of the front seat 51,

The covering sheet 52 attached so that peeling is possible by the aspect which coats the front surface and the hole 54 of (5).

The covering sheet 52 is the outermost layer of the light shielding layer 77 and the front sheet 51 which block light.

(In this 1st Embodiment, it is comprised by the laminated sheet containing the innermost layer which consists of a thermoplastic resin with small compatibility with the thermoplastic resin which comprises the weak adhesion layer 76.). In the first embodiment, the covering sheet 52 is made of PET (polyethylene terephthalate) nylon, aluminum foil, or the like on which the weakly bonding layer 78 and aluminum are deposited in order from the innermost layer, as shown in FIG. 3. The light shielding layer 77 which consists of these, and the reinforcement layer 79 which consists of PET, nylon, etc. are laminated | stacked, and is comprised. As the thermoplastic resin constituting the weak adhesive layer 78, a thermoplastic resin having a low compatibility with the thermoplastic resin constituting the weak adhesive layer 76 of the front sheet 51 is employed, for example, the weak adhesive layer 76. When comprised with this polyethylene, polypropylene, polyethylene etc. which branded polypropylene are illustrated, and this coating sheet 52 can be peeled from the front sheet 51 relatively easily.

Moreover, although the said coating sheet 52 is welded in a predetermined part and is bonded to the front sheet 51 so that peeling is possible, the specific bonding structure of these sheets 51 and 52 is limited to this. Instead, for example, an adhesive layer may be provided on at least one bonding surface between the covering sheet 52 and the front sheet 51, and may be bonded to each other so as to be peelable through the adhesive layer.

Specifically, the covering sheet 52 is addressed to an approximately rectangular light shielding portion 52a covering the entire surface of the upper compartment 5 and the upper end of the light shielding portion 52a, and the hole 54 (hanger). A left and right symmetrical tongue section 52b covering the engagement section) is provided. That is, in the first embodiment, the hole 54 (hanger engaging portion) corresponds to the essential use portion. In the first embodiment, the case where the light shielding portion 52a and the speaker portion 52b are integrally formed as the covering sheet 52 is described as described above, but they are formed as separate bodies and connected to each other integrally. It may be.

As shown in FIG. 1 and FIG. 2, the light shielding portion 52a of the covering sheet 52 is peelable to the front sheet 51 in an aspect of covering the entire surface of the upper compartment 5 at its periphery. It is joined. In the state where the covering sheet 52 is bonded to the front sheet 51, the medicines accommodated in the upper compartment 5 by the light shielding layer 77 in the light shielding portion 52a are stored in the front sheet ( It is prevented from being exposed to light through 51, so that the inside of the upper compartment 5 cannot be visually confirmed through the front seat 51. On the other hand, when the covering sheet 52 is peeled off, the inside of the upper compartment 5 can be visually confirmed through the front sheet 51.

Moreover, on both sides of the part where the speech part 52b in the upper edge part of the said light shielding part 52a was produced, it has the notch part 52c cut and inserted in substantially triangular shape, and peeling of the coating sheet 52 is carried out. At the time, the light shielding portion 52a is cut out from the cutout 52c, and the light shielding portion 52a in the width direction central region is bonded to the back body in a state in which the bonding portions at both sides of the light shielding portion 52a are joined. It is to be able to peel off over the full length of the hanging direction of (2).

The protruding portion 52b of the covering sheet 52 is joined to the front sheet 51 at a position opposite to the light shielding portion 52a on the basis of the hole 54 so as to be peeled off, and in this bonding state, the hole ( The hole 54 is covered in a closed state, that is, in a state where a hanger such as a back stand cannot be properly inserted into the hole 54. Therefore, in the state where this speaker 52b is joined to the bag main body 2, the hole 54 is not in the state which interrupted use, ie, the function which functions as the hole 54, and the speaker 52b is By peeling, the hole 54 becomes a state which can be used.

More specifically, as shown in FIGS. 1 and 4, the junction 58 of the speaker 52b is a position deviating from the periphery of the hole 54 and is thin depending on the upper edge of the speaker 52b. It is formed long. Thus, by forming the junction part 58 in the position which deviated from the periphery of the hole 54, an excessive stress acts on the periphery of the hole 54 by peeling of the said projection part 52b, and the The bag main body 2 can be effectively prevented from being torn, such as delamination from the peripheral edge.

In addition, the shape of the said junction part 58 is not specifically limited, It sets suitably from a viewpoint of closing the hole 54. As shown in FIG. Therefore, for example, the shape of the joining portion 58 may be set to a circle, ellipse, square, arc shape, U-shape, or the like in the form of enclosing all or part of the hole 54.

Thus, the upper container 6 of the said structure is a light shielding layer part which comprises the light shielding layer 70 of the rear seat 50 and the light shielding layer 77 in the light shielding part 52a of the coating sheet 52. As shown in FIG. Is completely covered to almost completely. That is, since the upper compartment 5 in the upper container 6 is covered by the light shielding layer part, light entering into the upper compartment 5 can be blocked, so that the medicine contained in the upper compartment 5 is blocked. It can effectively prevent the appearance change by exposure to light. In addition, in the state where the upper compartment 5 is covered by the light shielding layer part, the inside of the upper compartment 5 cannot be visually confirmed, but a part of the said light shielding layer part is formed in the light shielding part 52a which can peel, and this difference Since the inside of the upper compartment chamber 5 can be visually confirmed by peeling the light portion 52a, it is possible to confirm the storage state of the medicine contained in the peeling of the light shielding portion 52a.

On the other hand, the lower container 8 is a flexible container having a substantially rectangular shape when viewed from the front, and is configured to accommodate a liquid agent in the lower compartment chamber 7. The lower container 8 is formed in a bag shape by joining the upper and lower ends of a normal sheet including thermoplastic synthetic resin by welding, and having the cylindrical discharge port 3 at a substantially central portion of the lower edge thereof. Is provided in the state connected to the lower compartment 7.

The lower container 8 is constituted so that the inside can be visually identified on a transparent sheet (including a translucent and colored transparent sheet), and a scale or the like indicating the amount of contents is printed on the side surface thereof (not shown). The transparent plain sheet which forms this lower container 8 is a sheet | seat formed of thermoplastic resins, such as polyethylene or a polypropylene. Moreover, the transparent normal sheet which forms the said lower container 8 is not limited to the thing of the said single layer structure, It is a multilayer structure, For example, the inner surface layer which consists of thermoplastic resins, such as polyethylene, from an innermost layer in order, The barrier layer which consists of PET on which silica was deposited, and the outer surface which consists of thermoplastic resins, such as polyethylene, may be laminated | stacked and comprised.

The specific bonding structure of this normal transparent sheet is firmly joined by welding in the state which inserted the discharge port 3 in the lower end part, but about protrudes from the lower edge of the said upper container 6 in the upper end part. It joins by welding in the state which opened the lower end part of the utility sheet 40 (refer FIG. 5). That is, in the chemical | medical agent bag 1 of this 1st Embodiment, the welding process of the lower end part of the lower container 8, and the connection process of both accommodation containers 6 and 8 are performed simultaneously.

Specifically, the lower end of the chamber sheet 40 is inserted into the upper opening of the lower container 8, and the upper end of the lower container 8 is interposed between the rear seat 50 and the front seat 51. The upper container 6 and the lower container 8 are connected by being sandwiched and welded in the overlapping part in this state. At this time, the lower end portion of the chamber sheet 40 is welded to the normal transparent sheet to form the chamber portion 4b. The chamber part 4b is also configured to be peelable by increasing the room pressure of the compartments 5 and 7, and thus the chamber sheet 40 is formed of a thermoplastic resin constituting the inner surface layer of the transparent ordinary sheet. It is formed of a thermoplastic resin having low compatibility.

Next, the usage description of the medicine bag 1 comprised as mentioned above is demonstrated.

First, in order to form in the state (usable state) which penetrated the medicine bag 1, especially the hole 54 for hanging and hanging the bag main body 2, the coating sheet 52 is peeled off.

Specifically, when the unbonded portion of the spreading portion 52b of the covering sheet 52 is removed by hand and pulled downward, the spreading portion 52b is peeled off from the bag main body 2 to form a hole 54. It is formed in a penetrating state. Since the speaker 52b is formed integrally with the light shielding portion 52a as the covering sheet 52, the light shielding portion 52a can also be peeled off in accordance with the pulling operation of the speaker 52b. In this way, the front surface of the front sheet 51 is exposed almost, and through the front sheet 51 it is possible to visually confirm the storage state of the drug contained in the upper compartment (5).

When the lower container 8 of the bag main body 2 is pressed by hand, the room pressure of the lower compartment chamber 7 becomes high, and the chamber part 4a, 4b peels accordingly, and the upper and lower partitions 5 ), (7) is in a communication state. In this state, the chemical | medical agent bag 1 is vibrated up and down, and the chemical | medical agent accommodated in both compartments 5 and 7 is mixed. That is, the mixed medicine which dissolves in the dissolution liquid accommodated in the lower compartment 7 by dissolving the medicine contained in the upper compartment 5 is prepared.

Even in this state, since the covering sheet 52 is peeled off and the entire front surface of the front sheet 51 is exposed, the mixed state of the respective medications is controlled through the front sheet 51 to approximately the entire length of the medicine bag 1. The confirmation work with a high degree of precision can be performed, for example, it can be easily judged whether there exists any chemical | medical agent which melt | dissolved.

Then, the hanger of the bag stand is inserted into the hole 54 of the bag main body 2, the medicine bag 1 (bag main body 2) is hung, the tube or the like is connected to the discharge port 3, and The mixed drug in the bag body 2 is administered to the patient via a tube or the like.

Here, for example, a user such as a doctor or a nurse forgets to peel off the cover sheet 52 at the time of trouble, and does not mix the medicines contained in the compartments 5 and 7, and thus the medicine bag 1 is not mixed. In the case where it hangs on the back stand, since the speech part 52b of the covering sheet 52 is coat | covered in the state which interrupted the hole 54, the medicine bag 1 is backed up. Can't hang on the stand. Therefore, the speech portion 52b is reliably peeled off in administering the medicine to the patient. In addition, by peeling the speech section 52b, as described above, the light shielding section 52a can also be reliably peeled off, and accordingly, the respective compartments 5, which see the medicine contained in the upper compartment 5, It turns out that the chemical | medical agent accommodated in (7) is not mixed. Therefore, at this point in time, the state of preservation of the medicine concealed by the light shielding layers 70 and 77 is visually confirmed, and then the medicine is mixed with the medicine contained in the lower compartment chamber 7, and the mixed state thereof. Can be visually confirmed.

That is, according to this medicine bag 1, the speech part 52b is peeled off as a formation work of the hole 54 which is a part of the operation | work immediately before administration, and the light shielding part 52a is also reliably according to the peeling work of this speech part 52b. Can be peeled off. In addition, the light shielding portion 52a is peeled off, so that the preservation state of the chemicals, the presence or absence of the mixing operation, the mixing state, and the like can be visually checked through the entire front surface of the front sheet 51 on which the light shielding portion 52a is peeled off. Thus, the mixed drug can be appropriately administered to the patient.

Moreover, although the medicine bag 1 which concerns on this 1st Embodiment was demonstrated above, it is also possible to change as follows, for example about this 1st embodiment.

(1) In the said 1st Embodiment, about the hole 54 formed in the hole formation area | region of the bag main body 2 beforehand, and the speaker 52b is arrange | positioned in the state which closed this hole 54. Although it demonstrated, the specific structure for forming in the state which penetrated the hole formation area | region by peeling the speech part 52b is not limited to this.

For example, as shown in FIG. 6, in the hole formation area | region (hanger engagement part) provided in the bag main body 2, the sewing trace 110 along the periphery of the hole 54 is provided previously, and the speech part 52b is provided. ) Is firmly bonded to the bag body portion 111 in the inside of the sewing mark 110 by welding, and the bag body portion inside the hole forming region 112 by peeling off the speech portion 52b. You may comprise so that 111 may be cut | disconnected and formed in the state which the hole 54 penetrated to the hole formation area 112. FIG. With this configuration, since the sewing marks 110 are formed only in the hole forming region 112 and the holes 54 are not formed before the slit portion 52b is peeled off, it hangs on the back stand or the like. Therefore, in order to form the hole 54, the slit part 52b is reliably peeled off, and the light shielding part 52a is also reliably peeled off by this.

(2) In the said 1st Embodiment, it is comprised so that the notch part 52c may peel off over the entire length of the direction which hangs only the width direction center area | region of the light shielding part 52a, but the notch part 52c is abbreviate | omitted suitably. can do. That is, in the chemical | medical agent bag 100 shown in FIG. 7, it is supposed to peel the whole covering sheet 152, without providing a notch.

(3) In the first embodiment, the covering sheet 52 covers the upper compartment 5 according to the hanging direction, that is, the covering sheet 52 covers the entire length of the upper compartment 5 in the vertical direction. Although it is arrange | positioned, the arrangement | positioning aspect of a coating sheet is not limited to this. For example, the cover sheet which can be peeled off may be provided so as to cover only the lower half of the upper compartment 5, and in this case, the configuration in which the upper half of the front sheet is shielded by the light shielding layer is adopted. However, as in the first embodiment, almost the entire front face of the front sheet is configured as a light transmitting portion, and when the cover sheet 52 is disposed so as to extend over the upper compartment 5, the cloth is hanged when the cover sheet is peeled off. The light-transmitting part of the front seat 51 is exposed over the full length of a direction (up-down direction), and the inside of the upper compartment 5 can be visually confirmed through the light-transmitting part of this front seat 51, and the confirmation of higher accuracy is confirmed. Work can be done.

(4) In the said 1st Embodiment, the upper partition chamber 5 arrange | positioned in the vicinity of the hole 54 among the upper and lower partition chambers 5 and 7 is made by the light shielding layers 70 and 77 which are light shielding layer parts. Although it is supposed to be covered, the partition chamber covered by the light shielding layer portion is not limited to the upper compartment chamber 5. That is, the lower compartment 7 may be covered by the light shielding layer part. However, if the upper compartment 5 is covered with the light shielding layer part and the medicine contained in the inside is shielded, the length of extension of the speech part can be as short as possible, thereby suppressing the material used. Economic burden can be reduced.

(5) Moreover, as shown in FIG. 7, the peeling handle 155 which is not bonded to the front sheet 151 is provided in the speech part 152b, and this peeling handle 155 is removed and the covering sheet 152 is removed. You may comprise so that peeling may be possible.

(6) In the first embodiment, the chamber portions 4a and 4b are formed by welding through the chamber sheet 40, but the chamber portions 4a and 4b are formed. Is not limited to the thing of said 1st Embodiment.

For example, you may comprise so that a chamber part may be set to the heat melting time shorter than another welding part, or welding pressure and temperature may be set to a small value, and it may peel by external force smaller than other welding part.

(7) In the first embodiment, the upper compartment 5 has a front surface formed by a light transmitting portion (front sheet 51), and the light blocking portion 52a covers the light transmitting portion. The sheet is also formed as a light transmitting portion, and the light blocking portion may be disposed so as to cover the front sheet and the rear sheet.

(8) The bag main body 2 of the first embodiment is formed by separately forming the upper container 6 and the lower container 8, and connecting them to each other. It does not specifically limit, For example, it may be formed in the state which divided | segmented the inside of the bag main body into several partition chambers by laminating two long rear seat | sheets and a front seat | sheet, and welding these sheet | seats at predetermined location.

Next, 2nd Embodiment of the medicine bag which concerns on this invention is described using FIGS.

As shown in FIGS. 8-10, the chemical | medical agent bag 201 of this 2nd Embodiment is the bag main body 2 of the rectangular shape which is substantially vertically long when viewed from the front similarly to 1st Embodiment, and this bag. The discharge port 3 provided in the lower part of the main body 2 is provided.

In 2nd-7th embodiment, the essential use part in which the speech part of the covering sheet 52 is arrange | positioned is provided in the lower part of the bag main body 2, and it is the discharge port 3 for discharging the chemical | medical agent in the chemical | medical agent accommodation chamber 4. It differs greatly from the said 1st Embodiment in the point. This point will be mainly described below. In the second embodiment, the same to almost the same configuration as the first embodiment is represented by the same reference numerals in the drawings, and the description thereof is omitted.

Also in this 2nd Embodiment, the upper container 6 is equipped with the coating sheet 252 joined so that peeling was possible with respect to the front surface of the said front sheet 51, and this coating sheet 252 is in this bonding state. The entire surface of the upper compartment 5 is covered.

The covering sheet 252 is shielded from the light-variable drug contained in the upper compartment 5, that is, is formed from the light shielding portion 252a having the light shielding layer 77 and the lower end of the light shielding portion 252a, The tongue 252b disposed in front of the lower compartment 7 and the discharge port 3a extending from the lower end of the tongue 252b to the discharge port 3, and disposed at the lower end of the discharge port 3, The port connection part 252c welded to the discharge port 3 so that peeling is possible is provided. That is, the port connection part 252c corresponding to the speech part is addressed to the light shielding part 252a via the tongue part 252b.

In addition, in the second embodiment, the light shielding portion 252a, the tongue 252b, and the port connecting portion 252c are formed as a covering sheet 252 by one sheet, but the present invention is not limited thereto. After forming the said light shielding part 252a, the tongue 252b, and the port connection part 252c separately, these may be integrally bonded and the coating sheet 252 may be comprised.

As shown in FIG. 8 and FIG. 9, the light shielding portion 252a of the covering sheet 252 covers the front sheet 51 in a state where the entire surface of the upper compartment 5 is covered at the peripheral portion P thereof. It is joined so that peeling is possible.

The tongue 252b is set to a width dimension that is slightly smaller than the width dimension of the light shielding portion 252a and extends in the vertical direction to conform to the surface of the lower container 8. On the other hand, the port connecting portion 252c is set to a width dimension smaller than the width dimension of the tongue 252b and slightly larger than the width dimension of the discharge port 3. In addition, in the state where the lower end of the port connecting portion 252c is bent to the rear side, the upper surface (that is, the rear surface before being folded) is welded to the lower surface of the discharge port 3 so as to be peeled off, and the discharge port 3 The outlet port 3a which opens toward the lower side of () is covered. In addition, the rear end of the port connecting portion 252c (that is, the lower end portion before being folded and bent) is extended to the rear side of the discharge port 3, and this extending portion extends the port connecting portion 252c from the discharge port 3. It functions as a peeling handle 252d held in the case of peeling.

Thus, the upper container 6 of the above structure is almost completely formed by the light shielding layer 70 of the rear sheet 50 and the light shielding layer 77 of the light shielding portion 252a of the covering sheet 252. It is covered. That is, since the upper compartment 5 in the upper container 6 is covered by the light shielding portion 252a, the light entering the upper compartment 5 can be blocked, so that the upper compartment 5 The drug contained in is exposed to light, and the appearance and the like are avoided from changing. In addition, when the upper compartment 5 is covered with the light shielding part 252a, the upper container 6 becomes in a state where the chemical | medical agent in the upper compartment 5 cannot be visually confirmed, but the said light shielding part When 252a is peeled from the upper compartment 5, it becomes a state which can visually confirm the inside of the upper compartment 5, and the state of the received chemical | medical agent can be confirmed by peeling off the light shielding part 252a.

On the other hand, the said discharge port 3 is equipped with the discharge port 3a which opens specifically downward, and the to-be-punched part (not shown) arrange | positioned inside this discharge port 3a. . The perforated part is formed of synthetic resin having elasticity and the like, and is punctured by puncture needles and the like, so that the medicine in the chemical storage chamber can be discharged into the needle, while the needle is pulled out to accommodate the medicine by the restoring force according to the elastic force. It is comprised so that the said discharge port 3a may be closed so that the chemical | medical agent of the room may not be discharged. In the second embodiment, since the discharge port 3a of the discharge port 3 is covered by the port connection part 252c of the covering sheet 252, the port connection part 252c is discharged to the discharge port 3. In the case of peeling off, the puncture part is exposed and a puncture needle or the like can be pierced in the puncture part.

Next, the procedure in the case of using the chemical | medical agent bag comprised as mentioned above is demonstrated.

do.

First, in order to expose the perforated part of the discharge port 3, the peeling handle 252d of the port connection part 252c is grasped and displaced downward, and the port connection part 252c is removed from the discharge port 3. Peel off. Again, by displacing the port connecting portion 252c to the front side, the light shielding portion 252a joined at the peripheral portion P is peeled off from the front sheet 51.

Next, when the lower container 8 of the bag main body 2 is pressed by hand, and the room pressure of the lower compartment chamber 7 becomes high, the chamber parts 4a and 4b peel and match with this pressure. Both compartments 5 and 7 are in communication. In this state, the chemical | medical agent bag 1 is vibrated up and down, and the chemical | medical agent accommodated in the two compartments 5 and 7 is mixed.

Then, the hanger of the bag stand is inserted into the hole 54 of the bag main body 2, the medicine bag 1 (bag main body 2) is hung, and the puncture needle is punctured with respect to the perforations of the discharge port 3. The mixed drug in the bag body 2 is administered to the patient via a tube connected to the puncture needle.

As described above, according to the medicine bag 201, the port connecting portion 252c of the covering sheet 252 covers the discharge port 3a of the discharge port 3, so that the medicine in the medicine chamber 4 Since it is attached to the discharge port 3 so as to prevent discharge, when the medicine bag 1 is used, the port connecting portion 252c is removed from the discharge port 3 as a series of administration operations for discharging the medicine. It is necessary to peel off. In the process of peeling off the port connecting portion 252c from the discharge port 3, as the port connecting portion 252c constituting a part of the covering sheet 252 is peeled from the discharge port 3, the covering sheet ( The user may be aware that 252 is attached to the bag body 2 and that the covering sheet 252 should be peeled off from the bag body 2. On the other hand, as the port connecting portion 252c is peeled from the discharge port 3 as described above, the entire covering sheet 252 including the port connecting portion 252c can be peeled from the bag main body 2 as a result. The light shielding portion 252a of the sheet 252 may also be peeled off from the bag body 2 to visually confirm the presence of the medicine shielded by the light shielding portion 252a to the user.

As described above, the drug bag 201 reliably performs peeling of the coating sheet 252 in a process immediately before a series of administrations, so that the mixed state, the preservation state, and the like of the drug can be visually confirmed. Can be appropriately administered.

In the second embodiment, the cover sheet 252 is attached to the discharge port 3 so as to cover the discharge port 3a. Alternatively, the cover sheet 252 may be replaced with the above configuration.

Fig. 11 is a partial cross-sectional view showing a third embodiment of the present invention, and since the back main body 2 and the discharge port 3 have the same configuration as in the second embodiment, about these structures, In addition, the same description is attached | subjected and the description is abbreviate | omitted.

With reference to FIG. 11, the tamper seal S is joined to the discharge port 3 of the chemical | medical agent bag 201 so that peeling is possible. The tamper seal S is disposed so as to cover the discharge port 3a and is bonded to the discharge port 3 so as to prove that the medicine bag 201 is an unused article. In other words, since the puncture needle or the like cannot be punctured against the perforated portion of the discharge port 3 without removing the tamper seal S, the tamper seal S is used when the chemical bag 201 is used. It is necessarily peeled from the discharge port (3).

On the other hand, the covering sheet 252 includes the light shielding portion 252a and the tongue portion 252b described above, and a thread connecting portion 252e fixed to the tamper seal S is provided at the lower end of the tongue portion 252b. It is addressed. Since the thread connecting portion 252e is fixed to one end of the tamper seal S (the front end in the figure), the tamper seal S is removed from the discharge port 3 when the medicine bag 1 is used. When it peels, it will displace with the said tamper seal S. FIG.

According to the chemical | medical agent bag 1 comprised as mentioned above, since the thread connection part 252e of the said coating sheet 252 is affixed with respect to the tamper seal S which peels off at the time of use of the discharge port 3, the chemical | medical agent bag ( In the case of using 1), the thread connecting portion 252e is also displaced with respect to the bag main body 2 in conjunction with the operation of excluding the tamper seal S included in a series of immediately before administration for discharging the medicine. As the tamper seal S with the seal connecting portion 252e is peeled off from the discharge port 3, the covering sheet 252 is attached to the bag main body 2, and the covering sheet 252. Can be recognized by the user that is to be peeled off from the bag body 2. On the other hand, as the tamper seal S is detached from the discharge port 3 as described above, the entire covering sheet 252 having the seal connecting portion 252e attached to the tamper seal S is provided with the bag main body 2. As a result, the light shielding portion 252a of the covering sheet 252 is also peeled from the bag main body 2 so that the presence of the medicine shielded by the light shielding portion 252a can be visually confirmed to the user. Can be.

Moreover, according to the chemical | medical agent bag 1 of the said embodiment, since the light shielding part 252a is connected to the tamper seal S as mentioned above, in the process of manufacturing a chemical | medical agent bag conventionally, a coating sheet When the seal connecting portion 252e is connected to the tamper seal S when the 252 is coated, the medicine bag 1 of the present invention is relatively easy in the state where the conventional manufacturing method of the medicine bag is maintained as possible. Can be prepared.

In addition, a chemical | medical agent bag can also be set as the following structure instead of the structure of said 1st-3rd embodiment.

It is a front view which shows the chemical | medical agent bag which concerns on 4th Embodiment of this invention, and FIG. 13 is sectional drawing along the XIII-XIII line of FIG. Moreover, in the medicine bag 301 which concerns on 4th Embodiment, the structure of the said upper container 6 and the lower container 8 of 1st Embodiment was inverted up and down, ie, the said upper container ( The discharge port 3 is provided with respect to the lower end part of the lower container 30O8 of this embodiment which has the structure similar to 6), and the upper part of this 4th embodiment which has the same structure as the said lower container 8 The hole 54 is formed in the upper end part of the accommodation container 306. That is, the drug of the photovariable powder is accommodated in the lower compartment 3O7 of the lower container 3O8, while the drug of the powder is dissolved in the upper compartment 3O5 of the upper container 3O6. Dissolution liquid is contained in the upper compartment 3O5 and the lower compartment 307, and the chemical solution 104 in the bag main body 2 is formed in the chamber portions 4a, 4b (in each of the above-described embodiments, To be in an inverted position).

The chemical | medical agent bag 301 is provided with the front and back both sides of the lower compartment chamber 307, and a pair of covering sheet 352 arrange | positioned so that the discharge port 3 may be coat | covered. Each of the cover sheets 352 is made of a light-impermeable synthetic resin or the like having substantially the same structure as the light shielding portion 252a, and the front sheet of the body sheet 352a and the body sheet 352a which are substantially rectangular in front view. The peeling knob 352b extended laterally from the lower end part is provided. These main body sheets 352a are welded to each other at the peripheral edge portion R so as to be peelable from each other, and the upper edge portion of the peripheral edge portion R sandwiches the front seat 51 and the rear seat 50, It is welded with these so that peeling is possible.

As described above, each covering sheet 352 covers the front and rear sides of the lower compartment 3O7, thereby avoiding the drug in the lower compartment 3O7 from being exposed to light through the front seat 51, and thus the medicine bag 301. The outside of the bottom through the front seat 51 is in a state that can not visually check the interior of the lower compartment (30). That is, the part corresponding to the lower division chamber 307 of this main body sheet 352a corresponds to a light shielding part. On the other hand, by peeling each said peeling handle 352b so that they may mutually separate, the welding part in the periphery part R of each coating sheet 352 will peel, and the said lower compartment chamber 307 will be in the state exposed, In this state, the medicine in the lower compartment 307 can be visually confirmed through the front seat 51.

In other words, the respective covering sheets 352 are separated from each other by separating the peeling knobs 352b from each other in the covering position disposed to cover the discharge port 3, so that the exposed position of the discharge port 3 is exposed. It is configured to be displaceable. As described above, in the fourth embodiment, the lower end of each covering sheet 352 constitutes a port covering portion 352c for embodying the covering position and the exposed position, and the port covering portion 352c. ) Corresponds to the speech section.

And when using the said chemical | medical agent bag 301, instead of the operation | work which peels the port connection part 252c in the said embodiment from the discharge port 3, each said covering sheet 352 is peeled mutually, Then, each port covering portion 352c is made to have an exposed position.

According to the chemical | medical agent bag 301 comprised as mentioned above, the displacement material to the exposure position which exposes the discharge port 3 in the covering position which the port covering part 352c of the said covering sheet 352 covers the discharge port 3, Since the chemical | medical agent bag 301 is used, it is necessary to displace each port coating part 352c in the said covering position to an exposure position in order to discharge | release a chemical | medical agent. In the process of displacing each of the port covering portions 352c to the exposed position, as the port covering portions 352c constituting a part of the covering sheets 352 are peeled off (displaced), the covering sheet 352. Is attached to the bag body 2, and the user can recognize that each of the covering sheets 352 should be peeled off from the bag body 2. On the other hand, as the port coating portion 352c is displaced to the exposure position as described above, the entire covering sheet 352 can be peeled off from the bag body 2, and as a result, the medicine shielded by the covering sheet 352 The presence of can be visually identified for the user.

In the fourth embodiment, the front and rear sides of the lower container 30 are covered with a pair of covering sheets 352. Instead of this configuration, it is also possible to have the following configuration.

14 is a partial cross-sectional schematic view of the medicine bag according to the fifth embodiment of the present invention. In addition, about the structure except the said coating sheet 352, since it is the same as the chemical | medical agent bag 301, these structures are attached | subjected with the same code | symbol, and description is abbreviate | omitted here.

The chemical | medical agent bag 401 of this embodiment is a coating sheet instead of the said coating sheet 352.

Equipped with (452). The covering sheet 452 is formed of a light-impermeable synthetic resin or the like having substantially the same configuration as the light shielding portion 52a, extends downward from the upper end of the front surface of the lower container 30, and simultaneously discharges the discharge port 3. It is folded back from the bottom of, and is arranged to extend to the upper rear end of the lower container 30. The coated sheet 452 folded in this way is formed in a bag shape as a whole by being detachably welded at the upper side and the left and right sides, respectively, and at the welding position of the upper side, the front sheet 51 and the rear seat. (50) is sandwiched. That is, the cover sheet 452 is folded back and welded so that it can be peeled off, thereby forming a bag shape in which the lower compartment chamber 307 and the discharge port 3 are accommodated, and at the same time, the lower container ( It is fixed with respect to the front and rear both surfaces in the upper end part of 3O8). In addition, one end of the covering sheet 452 extends above the welding position with the rear surface of the lower container 300 to form the peeling handle 452b.

As described above, the covering sheet 452 covers the front and rear sides of the lower compartment 3O7, thereby avoiding the drug in the lower compartment 3O7 from being exposed to light through the front seat 51, and thus, the medicine bag 401. In the outside of the lower compartment through the front seat 51 (307) is in a state that can not be visually confirmed. On the other hand, by holding the peeling handle 452b apart from the bag main body 2 to separate it, the welded portion to the lower compartment 307 is peeled off, and the cover sheet 452 is displaced downward to displace the lower compartment 3O7 and discharge. The port 3 is exposed, and in this state, the medicine in the lower compartment 307 can be visually confirmed through the front seat 51.

In other words, the respective covering sheets 452 are separated from the covering position disposed so as to cover the discharge port 3 so as to separate the peeling handles 452b from the bag main body 2 so as to separate the discharge ports 3. ) Is configured to be displaceable to the exposed position. As described above, in the present embodiment, the middle portion where the covering sheet 452 is bent is formed to form the port covering portion 452c for embodying the covering position and the exposed position. 452c) corresponds to the speech section.

In the case where the medicine bag 401 is used, these cover sheets 452 are peeled off from the lower compartment chamber 307, and the port coating portion 452c is exposed to the exposed position.

According to the chemical | medical agent bag 401 comprised as mentioned above, the port coating part 452c of the said coating sheet 452 is displaced by the exposure position which exposes the discharge port 3 from the covering position which coat | covers the discharge port 3; Since it is excreted as, the same effect as the said medicine bag 3O1 can be achieved.

In addition, in said 4th and 5th embodiment, although the front and back both sides of the lower container 30 are covered, it can also be set as the following structure instead of this structure.

FIG. 15 is a partial cross-sectional view of a medicine bag according to a sixth embodiment of the present invention. FIG. In addition, about the structure except the said coating sheet 452, since it is substantially the same as the medicine bag 401, the same code | symbol is attached | subjected about these same structures, and description is abbreviate | omitted here.

The chemical | medical agent bag 501 of this 6th Embodiment is equipped with the coating sheet 552 instead of the said coating sheet 452. The covering sheet 552 includes a light shielding portion 552a having the light shielding layer 77, a tongue 552b extending from the lower end of the light shielding portion 552a toward the discharge port 3, and the tongue 552b. It is provided at the lower end of the cover and has a cover 552c that can be fitted to the discharge port 3 from the outside. Like the medicine bag 1, the said light shielding part 552a is welded to the lower container 30O so that the chemical | medical agent in the said lower compartment 3030 may be shielded. The tongue 552b is provided with the light shield 552a and the cover 552c so that the cover 552c can be shifted from the cover position covering the discharge port 3 to the exposed position exposing the discharge port 3. It is prepared to connect.

In the case of using the medicine bag 501, the cover 552c at the cover position covering the discharge port 3 is removed from the discharge port 3, and the discharge port 3 is exposed. The displacement is performed to the exposure position.

According to the chemical | medical agent bag 50 comprised as mentioned above, the cover 552c of the said covering sheet 552 is excreted as a displacement material by the exposure position which exposes the discharge port 3 in the covering position which coat | covers the discharge port 3. As a result, the same effect as that of the medicine bag 50 can be achieved.

Moreover, the chamber part 4c is provided in the said chemical | medical agent bag 501, The lower compartment 3O7 is partitioned into two compartments 3O7a and 307b by this chamber part 4c. . Among these compartments 307a and 30b, the compartment which communicates with the discharge port 3 (henceforth shown as the lower compartment 3O7b) is formed in the empty space which a chemical | medical agent is not filled.

According to this configuration, even if a series of administration operations are performed in a state where the drugs in each of the compartments 3O7 and 3O5 are not mixed, the lower compartment 3O7b communicating with the discharge port 3 is empty. Since it becomes possible to hold the chemical | medical agent in the chemical | medical agent accommodation chamber 10 by non-emission, administration of an inappropriate chemical | medical agent can be suppressed.

In the sixth embodiment, the discharge port 3 is covered by the lid 552c. Instead of this configuration, it is also possible to employ a covering sheet having the port connection portion 52c described above. Do.

FIG. 16 is a partial cross-sectional schematic view of the medicine bag according to the seventh embodiment of the present invention. FIG. In addition, in the structure except the said covering sheet 552, since it is substantially the same as the chemical | medical agent bag 501, about the same structure, the same code | symbol is attached | subjected and description is abbreviate | omitted here.

The chemical | medical agent bag 601 of this embodiment is equipped with the coating sheet 652 instead of the said coating sheet 552. The covering sheet 652 extends from the light shielding portion 652a having the light shielding layer 77 and the lower end of the light shielding portion 652a, and is discharged 3a similarly to the port connecting portion 252c (see FIG. 9). ) Is provided with a port connecting portion 652c welded to the discharge port 3 so as to be peeled off. Like the medicine bag 1, the said light shielding part 652a is welded with respect to the lower container 30O so that the chemical | medical agent in the said lower compartment 307 may be light-shielded.

When the medicine bag 601 is used, the light shielding portion 652a of the cover sheet 652 is peeled off from the discharge port 3 and the light blocking portion 652a is lowered in the lower container 3010. ) To peel off.

According to the chemical | medical agent bag 601 comprised as mentioned above, the port connection part 652c of the coating sheet 652 coat | covers the discharge port 3a of the discharge port 3, and interrupts discharge | release of the chemical | medical agent in the chemical | medical agent accommodation chamber 104. Since it is attached to the discharge port 3 so as to achieve the same effect as the medicine bag 20l.

In addition, since the chamber 4c is provided in the chemical | medical agent bag 6O1 similarly to the chemical | medical agent bag 50O1, a series of administration operations are performed in the state in which the chemical | medical agent in each compartment 307a, 305 is not mixed. Even if it is, even if the lower compartment 307b which communicates with the discharge port 3 is formed as a vacancy, administration of an inappropriate chemical | medical agent can be suppressed.

In the second to seventh embodiments, the port connecting portion 252c, the port covering portions 352c and 452c, and the outer side of the seal connecting portion 252e (that is, the bag main body 2). Ivan

On the surface of the (reversed side), for example, as illustrated in FIG. 12, it is necessary to peel off the covering sheets 252, 352, 452, and 552 from the bag body 2. It is also possible to form a contact column (V) indicating.

According to the above configuration, when the port connecting portion 252c, the port covering portions 352c and 452c and the seal connecting portion 252e are operated in the process of performing a series of operations immediately before administration, the covering sheet 252, It is possible to more reliably recognize to the user that 352, 452 and 552 should be peeled off from the bag body 2.

In addition, in the said chemical | medical agent bags 301 and 401 of the said 4th and 5th embodiment, the front and back both sides of the lower container 308 are coat | covered with the covering sheet 352 and 452. Therefore, the rear seat 50 does not necessarily have to have light shielding properties. When the rear seat 50 is formed of a light-transmissive resin, both side surfaces of the front seat 51 and the rear seat 50 are formed. As a result of being able to check the state of the medicine inside, it is possible not only to omit the trouble of inverting the front and back of the bag body 2 when checking the remaining amount of the medicine, and also to properly check the injection state of the medicine, Relief may be provided for the patient injected with the drug. In this case, the front seat 51 and the rear seat 50 of the lower container 3O8 correspond to the light-transmitting part, and the chemical agent accommodated in the lower container 3O8 can be visually confirmed through the light-transmitting part. .

In addition, in the said chemical | medical agent bags 3O1 and 4O1 of the said 4th and 5th embodiment, the front and back both sides of the lower container 30O are covered with the covering sheet 352 and 452. Therefore, for example, an oxygen scavenger or a desiccant may be disposed in a space covered with the cover sheets 352 and 452 outside the lower container 30. By doing in this way, when the chemical | medical agent in the said lower container 308 is a thing with dioxide property or hygroscopicity, oxidation and moisture absorption of the said chemical agent at the time of storage of a medicine bag can be suppressed.

In addition, in each said embodiment, although the chamber part 4a, 4b is formed by welding through the chamber sheet 40, it is not limited to this, For example, another chamber part welding is carried out. What is necessary is just to be comprised so that peeling can be carried out with the external force smaller than the other welding part by setting it to the heat-melting time shorter than a part, or setting welding pressure and temperature to a small value.

The bag body 2 of the second to seventh embodiments is formed by separately forming the upper container 6, 306 and the lower container 8, 308, and connecting them. However, the specific shape of the bag main body is not particularly limited, and for example, a plurality of compartments are formed inside the bag main body 2 by overlapping two long rear seats and a front seat and welding both sheets at a predetermined location. You may divide into.

In addition, in the above description, although the case where the light shielding parts 252a, 552a, 652a, and the main body sheet 352a light-shields the photovariable agent was demonstrated, it is not limited to this, For example, in order to suppress oxidation, moisture absorption, and transpiration of a chemical | medical agent, the aluminum sheet etc. which coat | cover the chemical | medical agent, etc. also comprise the said coating sheet. That is, the said light shielding parts 252a, 552a, 652a, and the main body sheet 352a should just coat | cover a chemical | medical agent so that it may become a state which cannot be visually confirmed from the outside.

Next, an eighth embodiment of the medicine bag according to the present invention will be described with reference to FIGS. 1 to 19.

As shown in these figures, the chemical | medical agent bag 701 of this 8th Embodiment is the bag main body 2 and the bag main body 2 of the rectangular shape which are substantially vertically long when viewed from the front similarly to 1st Embodiment. It has a discharge port (3) provided at the bottom of the.

The eighth to eleventh embodiments differ greatly from the first embodiment in that the essential use portion in which the speaker portion of the covering sheet 52 is disposed is a remaining amount display portion for displaying the remaining amount of the medicine contained in the medicine accommodation chamber 4. . This point will be mainly described below. In the eighth embodiment, the same to almost the same configuration as the first embodiment is denoted by the same reference numerals in the drawings, and the description thereof is omitted.

Also in this 8th embodiment, the lower container 8 which comprises the lower compartment 7 is provided.

On the side surface of the lower container 8, a scale portion M1 serving as an index for the level of the remaining amount of drug in the drug storage chamber 4, and the remaining amount indicating the remaining value of the drug corresponding to the scale portion M1. Numerical part S1 is printed. That is, the scale part M1 is an index for the level of the mixed drug in which the drugs in the upper compartment 5 and the drugs in the lower compartment 7 are mixed, and the amount of the medicine corresponding to the level is the remaining amount value S1. ) Is indicated by a numerical value. In this embodiment, three types of 75 mL, 50 mL, and 25 mL are arranged in an up-down direction, and the scale part M1 is formed in the vertical position corresponding to these. In addition, in this embodiment, the said graduation part M1 and the residual amount value part S1 comprise an example of the residual amount display part H. In addition, in FIG.

On the other hand, the cover sheet 752 is joined to the upper container 6 so that peeling is possible with respect to the whole surface of the said front sheet 51 similarly to 1st Embodiment.

The covering sheet 752 shields the light-variable drug contained in the upper compartment 5, that is, the light shielding portion 752a having the light shielding layer 77 and the lower portion of the light shielding portion 752a. And a concealed portion 752b (speech portion) which is disposed in front of the lower compartment 7 and prevents the use (visual observation) of the remaining amount display portion H. In addition, in the eighth embodiment, the concealing portion 752b and the lower container 8 are not bonded to each other, and the concealing portion 752b moves the light shielding portion 752a from the front sheet 51. It is supposed to function as a grab handle for peeling off.

As shown in FIG. 17 and FIG. 18, the light shielding portion 752a of the covering sheet 752 covers the entire surface of the upper partition chamber 5 at the periphery of the front sheet 51. It is joined so that peeling is possible. In the state where the covering sheet 752 is bonded to the front sheet 51, the medicines accommodated in the upper compartment 5 by the light shielding layer 77 in the light shielding portion 752a are stored in the front sheet ( As a result of being avoided from being exposed to light through 51, the inside of the upper compartment 5 cannot be visually confirmed through the front seat 51 from the outside of the medicine bag 1. On the other hand, when the covering sheet 752 is peeled off, the front sheet 51 is in a state where the inside of the upper compartment 5 can be visually confirmed.

The said concealing part 752b is set to the width dimension slightly smaller than the width dimension of the said light shielding part 752a, and is extended in the up-down direction so that it may follow the surface of the lower container 8. In addition, in this embodiment, the concealment part 752b is the middle part of the lower container 8 so that the 75 mL part of the said residual amount value part S1 and the graduation part M1 corresponding to this may be concealed. Stretched to

Next, the procedure in the case of using the medicine bag 701 comprised as mentioned above is demonstrated.

First, in order to confirm the total amount of the chemical liquid in the medicine accommodation chamber 4, when the graduation portion M1 and the concealment portion 752b covering up the remaining amount value portion S1 are pulled upward, the operation is performed. Accordingly, the light shielding portion 752a joined at the peripheral portion P is also peeled from the front sheet 51.

Next, when the lower container 8 of the bag main body 2 is pressed by hand and the room pressure of the lower compartment chamber 7 becomes high, according to this pressure, the chamber parts 4a and 4b peel and fall up and down. Both compartments 5 and 7 are in communication.

Then, the hanger of the bag stand is inserted into the hole 54 of the bag main body 2, the medicine bag 1 (bag main body 2) is hung, and a puncture needle is punched against the punched part of the discharge port 3. The mixed drug in the bag body 2 is administered to the patient via a tube connected to the puncture needle.

As described above, according to the medicine bag 1, at least a portion (75 mL remaining value portion (75 mL) of the remaining amount display portion H provided in the lower container 8 is provided with the concealed portion 752b of the covering sheet 752. Since it is configured to conceal S1) and the corresponding scale portion Ml), when using the medicine bag 701, the remaining amount display portion H is used as a series of operations immediately before discharging the medicine. In order to confirm the remaining amount of the drug, it is necessary to expose the remaining amount display portion H from the concealment portion 752b. In the process of exposing the remaining amount display portion H from the concealment portion 752b, the cover portion 752b constituting a part of the covering sheet 752 is displaced from the bag main body 2, thereby covering the covering sheet ( The user can recognize that 752 is attached to the bag body 2 and that the covering sheet 752 should be peeled off from the bag body 2. On the other hand, as the concealed portion 752b is peeled off from the bag main body 2 as described above, the entire covering sheet 752 including the concealed portion 752b can be peeled off from the bag main body 2 as a result. The light shielding portion 752a of the sheet 752 is also peeled off from the bag main body 2, and the presence of the medicine shielded by the light shielding portion 752a can be visually recognized by the user.

As described above, the medicine bag 701 can visually confirm the mixed state, the preservation state, and the like of the medicine by reliably peeling off the coating sheet 752 in the course of performing a series of operations immediately before administration. As a result, the drug can be appropriately administered.

In the eighth embodiment, the concealment portion 752b is configured to conceal the residual volume portion Sl of 75 mL and the scale portion M1 corresponding thereto, but instead of this configuration, You may.

FIG. 2O is a front view illustrating a medicine bag according to a ninth embodiment, and since the bag main body 2 and the discharge port 3 have the same configuration as above, the same reference numerals are used for these same configurations. At the same time, the following description is omitted.

2O, the chemical | medical agent bag 801 of 9th Embodiment is equipped with the cover sheet 852. As shown in FIG. This covering sheet 852 is provided with the light shielding part 852a which has the structure similar to the light shielding part 752a mentioned above, and the concealment part 852b which protrudes below this light shielding part 852a. Like the light shielding portion 52a, the light shielding portion 852a is bonded to the front sheet 51 of the upper container 6 so as to be peeled off from the peripheral portion P so as to shield the medicine in the upper compartment 5. It is supposed to. On the other hand, the concealment portion 852b is formed in a rectangular shape extending in the vertical direction, the lower end portion is in the welding portion of the lower container 8 (that is, the welding portion for constituting the lower end portion of the lower compartment chamber 7). It is joined so that peeling is possible in the junction part J1.

In addition, the chemical | medical agent bag 801 of 9th Embodiment carries out the connection process of the upper container 6 and the lower container 8 with the closing process of the upper end part of the lower container 8, and is then a covering sheet. 852 is detachably joined to the front sheet 51 at the peripheral portion P of the light shielding portion 852a, and then the concealed portion 852b protruding below the light shielding portion 852a is attached to the lower container ( It is manufactured by joining so that peeling is possible at the junction part J1 with respect to the welded part of 8).

Thus, the middle part of the concealment part 852b joined to the lower container 8 is arrange | positioned so that all the indications of the residual amount value part S1, ie, 75 mL, 50 mL, and 25 mL, may be concealed. In addition, the concealment portion 852b is extended to a position slightly lower than the joining portion J1 so that the speech portion functions as a grab handle 852c for peeling off the covering sheet 852 from the bag body 2. It is.

When using the chemical | medical agent bag 801 comprised as mentioned above, in order to confirm the residual amount of chemical | medical solution in the said chemical | medical agent accommodation chamber 4, the concealment part 852b which conceals the whole residual amount value part S1 as mentioned above is closed. By grasping the holding handle 852c and pulling it upward, the concealed portion 852b is peeled off from the bonding portion JI, and at the same time, the light shielding portion 852a is also peeled off from the peripheral portion P. After peeling off the cover sheet 852 from the bag main body 2 in this way, the operation | movement just before administration mentioned above is performed, and mixed medicine is administered to a patient.

As described above, according to the chemical | medical agent bag 801, when the concealment part 852b hides the whole residual value part S1, when confirming the chemical | medical agent total amount as a series of operation immediately before dispensing a chemical | medical agent, As a result of the need to peel the concealed portion 852b out of the bag body 2, the user can be recognized that the concealed portion 852b should be peeled off from the bag body 2.

Moreover, according to the chemical | medical agent bag 801 of the said 9th embodiment, since the said cover part 852b is attached so that peeling is possible with respect to the bag main body 2 at the junction part J1, it is concealed in order to confirm a chemical | medical agent total amount. When it is necessary to peel the part 852b from the bag main body 2,

As a result, the covering sheet 852 is attached to the bag main body 2 as the cover part 852b which comprises a part of the said covering sheet 852 peels from the bag main body 2, and this covering sheet The user can be surely recognized that 852 should be peeled off from the bag body 2.

Moreover, in the said chemical | medical agent bag 801, although the concealment part 852b hides the whole remainder value part S1, it is not limited to this, It is also possible to conceal the whole of the graduation part M1. In addition, as described in the first embodiment, it is also possible to conceal the entirety of both the residual value numerical portion S1 and the scale portion M1.

FIG. 21 is a front view showing a medicine bag according to a tenth embodiment, and since the bag main body 2 and the discharge port 3 have the same configuration as above, the same reference numerals are used for these same configurations. In addition, the following description is abbreviate | omitted.

With reference to FIG. 21, the chemical | medical agent bag 901 of 10th Embodiment is equipped with the cover sheet 952. As shown in FIG. The covering sheet 952 includes a light shielding portion 952a having the same configuration as the light shielding portion 752a described above, and a concealed portion 952b protruding downward from the light shielding portion 952a. Similarly to the light shielding portion 752a, 952a is bonded to the front sheet 51 of the upper container 6 so as to be peeled off from the peripheral portion P, and shields the medicine in the upper compartment 5. On the other hand, the concealment portion 952b is set to a width dimension slightly smaller than the width dimension of the light shielding portion 952a, extends in the vertical direction so as to conform to the surface of the lower container 8, and at the same time, the lower end thereof is lowered. The welded portion of the storage container 8 is joined to each other at a pair of left and right joints J2 so as to be peeled off.

In addition, the chemical | medical agent bag 901 of 10th Embodiment performs a connection process of the upper container 6 and the lower container 8 simultaneously with the closing | closing process of the upper end part of the lower container 8, and then a covering sheet. (952) is detachably joined to the front sheet 51 at the peripheral portion (P) of the light shielding portion (952a), and then the concealed portion (952b) protruding below the light shielding portion (952a) the lower container ( It is manufactured by joining so that peeling is possible in the left-right paired junction part J2 with respect to the welded part of 8).

In this way, the middle portion of the concealed portion 952b joined to the lower container 8 is the remaining amount value portion.

It is arrange | positioned so that the whole of S1 and the graduation part M1 may be concealed. In addition, the said cover part 852b has the left side part spoken to the position slightly lower than the said junction part J2, and this part becomes a grasp handle 952c for peeling off the covering sheet 952 from the bag main body 2. As shown in FIG. It is supposed to function. In addition, a contact column (V) indicating that the cover sheet 952 needs to be peeled from the bag main body 2 on the surface of the separated side with respect to the bag main body 2 in the concealment portion 952b. Is printed.

When using the chemical | medical agent bag 901 comprised as mentioned above, in order to confirm the residual amount of the chemical | medical solution in the said chemical | medical agent accommodation chamber 4, the said concealment which hides the residual value part S1 and the graduation part M1 as mentioned above. By grasping the handle 952c holding the portion 852b and pulling it upward, the concealed portion 952b is peeled off at each junction J2, and at the same time, the light shielding portion 952a is also removed from the peripheral portion P. Peel off. After peeling off the cover sheet 952 from the bag main body 2 in this way, the above-mentioned operation is performed just before, and a mixed medicine is administered to a patient.

As described above, according to the chemical | medical agent bag 1001, the concealment part 952b is a residual amount value part.

By concealing the entirety of S1 and the graduated portion Ml, it is necessary to peel the concealed portion 952b from the bag body when confirming the total amount of the drug as a series of operations immediately before dispensing the drug. As a result, the user can recognize that the concealment 952b should be peeled off from the bag body 2.

Moreover, according to the said chemical | medical agent bag 1001, it is necessary to peel off the said bag main body 2 coating sheet 952 on the surface of the said half with respect to the said bag main body 2 in the said concealing part 952b. Since the contact column (V) is formed to indicate that there is a gap, the cover sheet 952 should be peeled from the bag body when the concealment portion 952b is operated in the course of performing a series of administration operations. Can be more clearly recognized. In addition, in the said chemical | medical agent bag 9O1, it is described that it is necessary to peel the bag main body 2 and the coating sheet 952 with respect to the contact column (V), It is not limited to this, An example is given. For example, the said hiding part 952b may hide the remaining amount display part H, and may describe both of these descriptions further.

Moreover, according to the chemical | medical agent bag 901 of the said 10th embodiment, since the said cover part 952b is attached so that peeling is possible with respect to the bag main body 2 at the junction part J2, it is concealed in order to confirm the chemical | medical agent total amount. As a result of the need to peel the part 952b from the bag main body 2, as a result, the cover part 952b which comprises a part of the said covering sheet 952 peels from the bag main body 2, and the covering sheet 952 is carried out. Can be reliably recognized by the user that is attached to the bag body 2 and that the covering sheet 952 should be peeled off from the bag body 2.

In addition, a medicine bag can also be set as the following structure instead of the structure of each said embodiment.

Fig. 22 is a front view showing the medicine bag according to the eleventh embodiment of the present invention, and Fig. 23 is a sectional view taken along the line XIII-XIII of Fig. 22.

With reference to each figure, the said chemical | medical agent bag 1001 of 11th Embodiment is the said upper container

The lower end part of the lower container 1010 of this embodiment which has the structure similar to the said upper container 6 of the said 1st Embodiment in the state which the structure of 6 and the lower container 8 reversed up and down. A discharge port 3 is provided for the upper portion, and a hole 54 is formed in the upper end portion of the upper container 1006 of the eleventh embodiment having the same configuration as the lower container 8. That is, the drug of the photovariable powder is accommodated in the lower compartment 1010 of the lower container 108, while the drug of the powder is dissolved in the upper compartment 1005 of the upper container 1006. Dissolution liquid is contained in the upper compartment 1010 and the lower compartment 107, and the medicine accommodation chamber 1004 in the bag body 2 is the chamber part 4a, 4b.

It is formed by being partitioned by (it becomes the position which reversed up and down with said each embodiment).

On the side surface of the upper container 1006, the remaining water number indicating the remaining portion number of the scale portion M2 as an index for the level of the remaining amount of the medication in the chemical storage chamber 1004 and the amount of the medicine corresponding to the scale portion M2. Tooth part S2 is printed. That is, the scale part M2 is an index for the level of the mixed drug in which the drug in the upper compartment 100 and the drug in the lower compartment 101 are mixed. S2) is represented by a numerical value. In the eleventh embodiment, two kinds of 125 mL and 100 mL are arranged in the vertical direction in the remaining amount value S2, and the scale portion M2 is disposed at the vertical position corresponding thereto. ) Is formed. In addition, in this embodiment, the said graduation part M2 and the residual amount value part S2 comprise an example of the residual amount display part H. As shown in FIG. In addition, although not shown in the figure, the scale part M2 and the remaining amount display part for displaying a residual amount smaller than the residual amount value part S2 are the side surface of the said lower container 1008 (namely, the covering sheet | seat ( Part covered with 1052).

The cover sheet 1002 is peelably joined to the lower surface container 1008 of the medicine bag 100 configured as described above with respect to the entire surface of the front sheet 51. The covering sheet 1052 has a light shielding portion 1052a for shielding the medicine in the lower compartment 1007 and a concealment portion which is directed at an upper end of the light shielding portion 1052a and is disposed in front of the upper compartment 10010. 1052b). In the present embodiment, the concealed portion 1052b and the upper container 100 are in a non-joined state, and the concealed portion 1052b is held by the light-shielding portion 1052a to be peeled off from the front sheet 51. It is supposed to function as a handle.

As shown in FIGS. 17 and 18, the light shielding portion 1052a of the covering sheet 1052 can be peeled off from the peripheral portion P with respect to the front sheet 51 while covering the entire surface of the lower compartment chamber 1007. Are bonded together. On the other hand, the said concealed part 1052b is set to the width dimension slightly smaller than the width dimension of the said light shielding part 1052a, and extends up and down so that it may conform to the surface of the upper container 1006. In addition, in this embodiment, the concealment part 1052b extends to the middle part of the upper container 1006 so as to conceal the whole of the said residual quantity value part S2 and the graduation part M2 corresponding to this. have.

Next, the procedure at the time of using the chemical | medical agent bag 1001 comprised as mentioned above is demonstrated.

First, in order to confirm the total amount of the chemical liquid in the drug storage chamber 104, when the scale portion M2 and the concealment portion 1052b concealing the remaining amount portion S2 are pulled down as described above, Accordingly, the light shielding portion 1052a joined at the peripheral portion P is also peeled from the front sheet 51.

Next, the upper container 100 of the bag main body 2 is pressed by hand, and the upper compartment chamber

When the room pressure of 1005 becomes high, chamber part 4a, 4b will peel in response to this pressure, and it will be in the state which the upper and lower compartments 1005 and 1007 communicated with. In this state, the chemical | medical agent bag 1001 is made to vibrate up and down, and the chemical | medical agent accommodated in both compartments 1005 and 1007 is mixed. In other words, the drug contained in the lower compartment 1007 is dissolved in the dissolution solution contained in the upper compartment 1005 to adjust the mixed drug administered to the patient.

Then, the hanger of the bag stand is inserted into the hole 54 of the bag main body 2, the medicine bag 1001 (bag main body 2) is hung, and the puncture needle is punctured with respect to the perforated part of the discharge port 3. The mixed drug in the bag body 2 is administered to the patient via a tube connected to the puncture needle.

As described above, according to the chemical | medical agent bag 1001, since the concealment part 1052b of the said covering sheet 1052 is comprised so that the residual amount display part H provided in the upper container 1006 may be concealed, In the case where 1001 is used, the remaining amount display portion H is exposed from the concealment portion 1052b because the remaining amount of the medication is checked using the remaining amount display portion H as a series of operations immediately before discharging the medication. It needs to be done. In the process of exposing the remaining amount display portion H from the concealment portion 1052b, as the concealment portion 1052b constituting a part of the covering sheet 1052 is displaced from the bag main body 2, the covering sheet ( The user can be aware that 1052 is attached to the bag body 2 and that the covering sheet 1052 should be peeled off from the bag body 2. On the other hand, as the concealed portion 1052b is peeled off from the bag main body 2 as described above, the entire covering sheet 1052 having the concealed portion 1052b can be peeled off from the bag main body 2, resulting in coating. The light shielding portion 1052a of the sheet 1052 is also peeled from the bag main body 2, so that the presence of the medicine shielded by the light shielding portion 1052a can be visually recognized by the user.

As described above, the medicine bag 1001 can reliably perform peeling of the coating sheet 1052 in the course of performing a series of operations immediately before administration, thereby visually confirming the mixed state, the storage state, and the like of the medicines. As a result, the drug can be appropriately administered.

In addition, the chemical | medical agent bags 7O1, 8O1, 9O1, and 1001 of said each embodiment are not limited to having two compartments as mentioned above, The chemical | medical agent bag provided with several compartments, for example For example, it is also possible to form the chemical | medical agent bag shown in FIG.

FIG. 24 is a partial cross-sectional view of a modification of the medicine bag 1001 of FIG. 23.

Referring to Fig. 24, the medicine bag 100l is provided with a chamber part 4c at a lower position of the chamber part 4a. The chamber part 4c has two lower compartment chambers 107. Compartments 1010a and 1007b. Among these compartments 1007a and 1007b, the compartment which communicates with the discharge port 3 (henceforth shown as the lower compartment 3O7b) is formed in the empty space which a chemical | medical agent is not filled.

According to the above constitution, even if a series of administration operations are performed in a state where the drugs in the compartments 1007a and 1005 are not mixed, the lower compartment 1010b communicating with the discharge port 3 is empty. Since it becomes possible, it becomes possible to hold | maintain the chemical | medical agent in the chemical | medical agent accommodation room 100 by non-emission, As a result, administration of an inappropriate pharmaceutical agent can be suppressed. In addition, since the lower compartment 1007b is formed into a vacancy, for example, when the powdered drug is contained in the lower compartment 1007b, the drug enters into the discharge port 3, The inconvenience that a drug melt | dissolves at the time of mixing can be prevented beforehand. In addition, since the chemicals can be prevented from entering the discharge port 3 as described above, it is unnecessary to form the discharge port 3 itself with a material having a barrier property such as light impermeability or oxygen impermeability. .

Moreover, in each said embodiment, although chamber part 4a, 4b, 4c is formed by welding through the chamber sheet 40O, it is not limited to this, For example, The chamber parts 4a, 4b, and 4c are set to have a shorter heating melting time than the other welded portions, or the welding pressure and temperature are set to a smaller value so that the chambers 4a, 4b and 4c can be peeled off with less external force than the other welded portions. Just do it.

Moreover, the bag main body 2 of each said embodiment is formed by separately forming upper container 6, 306, lower container 8, and 308, and connecting them, The bag main body Although the specific shape of is not specifically limited, For example, two long sheets of rear seat and a front seat are overlapped, and these sheets are welded at a predetermined location, and even if the inside of the bag main body 2 is divided into several compartments. do.

In addition, in the above description, the case where the light shielding parts 752a, 852a, 952a, and 1052a light-shields a photovariable drug was described, but it is not limited to this, for example In order to suppress oxidation, moisture absorption, and evaporation of the chemicals, the aluminum sheet covering the chemicals also constitutes the light shields 752a, 852a, 952a, and 1052a. That is, the said light shielding part 752a, 852a, 952a, and 1052a should just coat | cover a chemical | medical agent so that it may become a state which cannot be visually confirmed externally.

The concealed portions 752b, 852b, 952b, and 1052b may be configured so that the remaining amount display portion H hides at least a portion thereof, and is different from the above embodiments. It is also possible to conceal a part of the number in the numerical value part S1 so that the number cannot be read.

As described above, the medicine bag has a bag body having a medicine chamber that can accommodate a medicine in a state that can be visually confirmed through a light-transmitting portion provided at least in part, and the bag body includes the medicine chamber as a plurality of compartments. A medicine bag configured to divide a chamber portion so as to increase the room pressure of a particular compartment to remove the state of the chamber portion adjacent to the compartment, the medicine bag comprising: a covering sheet detachably attached to the bag body, and administration of the medicine The cover sheet further includes an essential use part used in the immediately preceding step, and the covering sheet is covered with a light shielding part for shielding a medicine contained in at least one compartment by covering a predetermined portion of the light transmitting part; With the covering sheet attached, it is provided with a speech portion disposed to prevent its use for the essential use portion.

With this configuration, since the speech section of the covering sheet is arranged to prevent its use with respect to the essential use section while the covering sheet is attached, a series of administrations for administering the medicine when the medicine bag is used. As the immediately preceding work, it is necessary to remove the speech portion disposed in the essential use portion. Then, if the speech part that obstructs the use of the essential use part is removed by the user, for example, the peeling part is removed, the light shielding part to which the speech part is spoken is also peeled off in this removal process, and the medicine shielded by the light shielding part is removed. It is exposed through the light emitter, thereby visually confirming the presence of the drug in the user, and allowing the user to see that the drugs are not mixed. In this way, in the process immediately before a series of administrations, by reliably peeling off the light shielding portion, it is possible to visually confirm the mixed state, the preservation state, and the like of the medicament to the user, so that the medicament can be appropriately administered. .

In the medicine bag, the essential use portion is a hanger engaging portion provided on the bag body for hanging and hanging the bag body, the speech portion may be detachably attached to the bag body so as to prevent the use of the hanger engaging portion. .

In this configuration, the speaker is joined to the bag main body so as to prevent the hanger engaging portion from being used. Therefore, unless the speaker is peeled off, the bag main body cannot be hung, for example, on a hanger of a bag stand, and thus mixed. As a series of operations immediately before administration for administering a drug to a patient, it is necessary for the user to peel the speech part from the bag body and to move the hanger engaging part into a usable state in a state where its use is hindered. When the speech part is peeled off, the light shielding part to which the speech part is delivered is also peeled off at this stage in the peeling process, and the drug shielded by the light shielding part is exposed through the light transmitting part to visually display the mixed state, the preservation state, etc. of the medicine. I can confirm it

The hanger engaging portion may be configured as a hole previously formed in the bag body, and the speech portion may be connected to a medicine bag having a hole that is blocked.

If comprised in this way, a hole can be reliably used only by peeling a coating sheet in a medical field.

The speaker may be joined to the bag body at a position opposite to the light shielding side on the basis of at least the hole.

In such a configuration, since the hole can be covered in a state in which the hole is reliably occluded, that is, in a state where the use is hindered, it is assured as a series of operations immediately before the administration to make the hole usable in an open state. The uneven part can be peeled off, whereby the light shielding part can be peeled even more reliably.

In addition, the speaker can be joined at a position deviated from the periphery of the hole.

That is, in the case where the bag main body is formed in advance, if the speech portion is joined to a predetermined portion of the bag main body at the periphery of the hole, the bag main body is torn at the periphery of the hole at the joining part, and in some cases May open the compartment. Therefore, when the speech portion is configured to be joined at a position deviated from the periphery of the hole as described above, stress concentration does not occur at the periphery of the hole, and tearing of the bag body can be effectively prevented.

In addition, at the periphery of the hanger engaging portion, an incision is provided in advance along the portion that becomes the periphery of the hole, while the speech portion is joined to the inside of the incision, and the bag body portion inside the incision is cut off by peeling the speech portion. Holes may be formed.

If comprised in this way, a hole can be reliably used only by peeling a speech part. In addition, since only the cutout portion is formed in the hanger engagement portion and is not formed as a hole, the speech portion is reliably peeled off to form the hole, and the light shielding portion is reliably peeled off by this peeling, thereby ensuring a covering sheet. Peeling can be performed to visually confirm the drug.

The cutout may be perforated.

If comprised in this way, a hole can be reliably formed by peeling of a speech part with a simple structure.

The light blocking portion and the speech portion may be integrally formed with each other.

If comprised in this way, a light shielding part will peel more reliably with peeling of a speech part. In addition, the integrated shading part and the speech part can improve the manufacturing efficiency compared to the case where they are separately manufactured and connected.

In addition, the light shielding portion is provided so that the light shielding portion can be placed in a hanging direction above the compartment in which the medicine shielded by the light shielding portion is accommodated.

In such a configuration, the light shielding portion is provided so that the light shielding portion can be placed in a hanging direction over its entire length above the compartment in which the medicine shielded by the light shielding portion is accommodated. Therefore, if the light shielding part is peeled off, the inside of the compartment can be visually confirmed over the entire length in the hanging direction, and a higher degree of confirmation work can be performed.

In addition, the light shielding portion may cover the light transmitting portion corresponding to the compartment disposed in the vicinity of the hole.

In this way, the speech part to be addressed to the light shielding part can be formed as short as possible, and the economic burden caused by the establishment of the speech part can be reduced as much as possible.

The essential use portion is provided at a lower portion of the bag main body and is a discharge port for discharging the medicine in the medicine storage chamber, and can be peeled off at least a part of the discharge port so that the speaker prevents the discharge of the medicine from the discharge port. Can be attached.

Since the speech part of the covering sheet is attached to the discharge port so as to prevent the discharge of the medicine in the medicine chamber, when the medicine bag is used, the speech part is discharged from the discharge port as a series of operations immediately before discharging the medicine. It is necessary to peel off. And in the process of peeling a speech part from a discharge port, as the speech part which comprises a part of the said covering sheet peels from a discharge port, the covering sheet is affixed to a bag main body, and the said covering sheet peels from a bag main body. Users can be aware that it should be.

In addition, when this speaker is peeled from the discharge port, the light shielding part where the speaker is extended is also peeled from the bag main body in this peeling process, and the drug shielded by the light shielding part is exposed through the light transmitting part, and the mixed state of the drugs is mixed. Visual status can be confirmed. As described above, the drug bag can be reliably peeled off of the coating sheet in a procedure immediately before a series of administrations, thereby visually confirming the mixed state, the preservation state, and the like of the drug. Can be.

The speaker may be attached to close the outlet of the discharge port.

In this way, unless the speech section is peeled off, the medicines in the medicine chamber cannot be discharged, and thus, a series of operations immediately before administration to administer the mixed medication to the patient, and the speech section is peeled off by the user from the discharge port. Therefore, it is necessary to connect a tube or the like for administering the medicine to the patient to the outlet. In this peeling process, the light shielding part is also peeled off at once, and the drug shielded by the light shielding part is exposed through the light transmitting part to visually confirm the mixed state, the preservation state, and the like of the drug.

The protruding portion includes a tamper seal that is released when the discharge port is in use, and the tamper seal may be attached to close the discharge port of the discharge port.

When comprised in this way, since the speech part of the said covering sheet | seat contains the tamper seal detached at the time of use of a discharge port, when using a medicine bag, the tamper seal included as a series of operation immediately before dispensing a medicine is used. In conjunction with the removal operation of, the speech section including this tamper seal is also displaced with respect to the bag body. Then, as the speaker is peeled off from the discharge port, the user can recognize that the covering sheet is attached to the bag body and that the covering sheet should be peeled from the bag body.

When the tamper seal is peeled off from the discharge port, the speech part including the tamper seal is also peeled off, and the light shielding part to which the speech part is extended is also peeled off from the bag main body in this peeling process and shielded by the light shielding part. Existing drugs are exposed through the light-transmitting unit to visually confirm the mixed state or the preservation state of the drugs. In this way, in the process immediately before a series of administrations, by reliably peeling off the coating sheet, it is possible to visually confirm the mixed state, the preservation state, and the like of the medicament, so that the medicament can be properly administered.

In addition, since the tamper seal is included in the speech section as described above, the speech section can be formed using, for example, an existing tamper seal, and relatively easily in a state where a conventional method for manufacturing a medicine bag is maintained. The pharmaceutical bag of the present invention can be produced.

The tamper seal is a thread provided to prove that the chemical bag is an unused article, in other words, the chemical solution cannot be discharged from the discharge port without removing the tamper seal.

The essential use portion is provided in the lower portion of the bag main body is a discharge port for discharging the medicament in the drug storage chamber, it can be provided in a state in which the discharge portion is coated with the discharge port to prevent the discharge of the drug from the discharge port. have.

If comprised in this way, since the extension part of the said covering sheet was provided in the state which covered the discharge port, it becomes necessary to displace from this covering position to the exposure position which exposes a discharge port. Then, as the speech portion constituting a part of the covering sheet is displaced to the exposure position, the user can recognize that the covering sheet is attached to the bag body and that the covering sheet should be peeled off from the bag body.

In addition, when this speaker is displaced to the exposed position, the light shielding part where the speaker is extended is also peeled off from the bag body in this displacement process, and the drug shielded by the light shielding part is exposed through the light transmitting part to mix the drugs. You can visually check the status or preservation status. As described above, by reliably peeling the coating sheet in the course immediately before the series of administrations, the mixed state, the preservation state, and the like of the drug can be visually confirmed, and thus the drug can be appropriately administered.

While both surfaces of the bag main body are covered by a pair of covering sheets facing each other, a pair of facing portions of these covering sheets facing each other are peeled off and bonded to each other, whereby the discharge port can be covered.

When comprised in this way, when using a chemical | medical agent bag, it is necessary to peel each speech part mutually, In this process of peeling, each coating sheet is affixed to the bag main body, and each said coating sheet is a bag main body. The user may be aware that it should be peeled off.

Moreover, when this speech part is peeled off, the light shielding part to which this speech part is speaking will also be peeled off from the bag main body in this peeling process, and the medicine shielded by the light shielding part is exposed through the light transmission part, and the mixed state of a chemical | medical agent and preservation are preserved. You can visually check the status and the like.

The compartment communicating with the discharge port may be formed as a vacancy in which the drug is not filled.

In such a configuration, even if the drug in each compartment is unmixed, even if the operation immediately before a series of administrations is performed, since the compartment communicating with the discharge port is formed as a vacant space, It is possible to maintain the discharge, which can suppress the administration of an inappropriate drug.

A contact column indicating that it is necessary to peel off the bag main body and the cover sheet may be formed on the surface of the speaker opposite to the bag main body side.

This configuration can more reliably recognize to the user that the covering sheet should be peeled from the bag body when the speech section is operated in the course immediately before a series of administrations.

The essential use portion is a remaining amount display portion provided on the surface of the bag body to display the remaining amount of the medicine contained in the medicine accommodation chamber, and the at least part of the remaining portion display portion provided in the compartment other than the compartment where the speech portion is shielded from the light shielding portion is concealed. It can be configured to.

In such a configuration, since the speaker section of the covering sheet is configured to conceal at least a part of the remaining amount display section provided in the compartments other than the compartments shielded from the light shielding portion, when a medicine bag is used, a series of As a work immediately before administration, it is necessary to expose the remaining amount display portion concealed in the speech section in order to confirm the total amount of medicines using the remaining amount display portion. In the process of exposing the remaining amount display portion, as the speech portion constituting a part of the covering sheet is displaced from the bag body, the covering sheet is attached to the bag body, and the covering sheet must be peeled from the bag body. The user may be recognized.

In addition, when this speech part is displaced, the light shielding part to which this speech part is spoken is also peeled from the bag main body in this displacement process, and the chemical | medical agent shielded by the light shielding part is exposed through the light transmission part, and the mixed state of a chemical | medical agent and storage You can visually check the status and the like. As described above, by reliably peeling the coating sheet in the course immediately before the series of administrations, the mixed state, the preservation state, and the like of the drug can be visually confirmed, and thus the drug can be appropriately administered.

The remaining amount display section includes a scale section as an index for the level of the remaining amount of medicine, and a remaining value numerical value indicating a remaining value of the medicine corresponding to the scale portion, and the speech section includes at least a portion of the scale portion or at least a portion of the remaining amount numerical portion. Or it can be comprised so that at least some of these may be concealed.

When comprised in this way, since the said speech part is comprised so that at least one part of the said graduation part, at least one part of a residual numerical value part, or both may be concealed, it becomes an index of the residual amount of a medicine before administration (that is, By concealing a part of the graduation part which shows the total amount of drugs in the medicine accommodation chamber, when confirming the total amount of drugs as a series of administration operations for discharging the drugs, it is necessary to peel the speech part from the bag body. Together, the light shielding part can be reliably peeled off.

The speech portion may be configured to conceal at least one scale portion and a residual value portion corresponding to the scale portion.

When comprised in this way, the said chemical | medical agent totals the chemical | medical agent quantity as a series of immediately before operation | movement for discharge | release of a chemical | medical agent, for example, by concealing the graduation part used as an index of the residual amount of medicine before administration, and the residual value numerical value part corresponding to this graduation part. When confirming that, it is necessary to peel the said speech part from a bag main body, and a light shielding part can be reliably peeled with this speech part.

The speech section may be configured to conceal the entirety of the scale section, the entirety of the remaining numerical values, or the entirety of both.

If comprised in this way, when the said speech part confirms the chemical | medical agent total amount as a series of administration operations for discharging a chemical | medical agent by concealing the whole scale part, for example, it is necessary to peel the said speech part from a bag main body, Along with this speech part, a light shielding part can be reliably peeled off.

On the surface opposite to the bag body side in the speaker section, a contact column indicating that the bag body and the cover sheet need to be peeled off, or that the speaker hides the remaining amount display part, or both of them are formed. Can be.

This configuration can more reliably recognize to the user that the covering sheet should be peeled from the bag body when the speech section is operated in the course immediately before a series of administrations.

The speech unit may be attached to the bag body so as to be peeled off.

When comprised in this way, in order to confirm a chemical | medical agent total amount, it is necessary to peel a speech part from a bag main body, and a light shielding part can be reliably peeled from a bag main body with this speech part.

As described above, in the medicine bag, the speech portion of the cover sheet is positioned so that the essential use portion is prevented from being used with the cover sheet attached to the bag body. Therefore, the speech section must be removed from the required use section so that the speech section can be used. The speech section is spoken in a shielding section that shields the medicine stored in the at least one compartment from light. That is, the removal of the speech portion causes the light shielding portion to peel off together from the bag body. Peeling of the light shielding portion exposes the corresponding light transmitting portion. The exposed floodlight allows the user to visually check the condition of the medications, for example how well they are mixed and how well they are preserved. Therefore, when the medicine is administered to the patient, the light shielding portion is reliably peeled off. Then, through the peeled and exposed light transmitting portion, the user is allowed to visually check the state of the medicines shaded by the light blocking portion, for example, how well they were preserved and how appropriately they were mixed. As a result, the agents can be appropriately administered to the patient.

This application is based on Japanese Patent Application Nos. 2003-86270, 2003-92661, and 2003-101632, which are incorporated herein by reference.

Although the present invention has been described fully with reference to the accompanying drawings, it should be understood that various changes and improvements will be apparent to those skilled in the art. Thus, unless these changes and improvements, in other respects, depart from the scope of the present invention, they should be construed as included in themselves.

As described above, according to the chemical | medical agent bag of this invention, since the speech part of a coating sheet is arrange | positioned so that the use of the said coating sheet may be interrupted to the said essential use part in the state attached to the bag main body, it is necessary to use an essential use part. Since the speech section must be removed from the mandatory use section, and the speech section is addressed to the shading section for shielding the medicine contained in the at least one compartment, the shading section can also be peeled off from the bag body at once. have. The peeling of the light shielding part exposes the corresponding light-transmitting part, and the user can visually confirm the preservation state, the mixed state, and the like of the medicines shielded by the light-shielding part through the exposed light-transmitting part. In this way, the shading part is reliably peeled off during the administration of the medicine to the patient, and thus the preservation state and the mixing state of the medicine can be visually confirmed through the peeled and exposed light-transmitting part, so that the mixed medicine is appropriately administered to the patient. can do.

Claims (5)

A bag body having a drug storage chamber capable of accommodating medicines in a state that can be visually identified through a light-transmitting portion provided at least in part is provided, and the bag body is provided with a chamber portion for dividing the drug storage chamber into a plurality of compartments. In the medicine bag configured to release the seal of the chamber portion adjacent to the compartment by increasing the room pressure of The cover sheet removably attached to the bag main body and the essential use part used immediately before the administration of the medicine are again provided. The covering sheet is used for the essential part in a state in which a light shielding part shields a medicine contained in at least one compartment by covering a predetermined portion of the light transmitting part, and the cover sheet is attached to the light shielding part and is attached to the light shielding part. Pharmaceutical bag, characterized in that having a speech portion disposed to interfere with. In the medicine bag of Claim 1, the said essential use part is a hanger engaging part provided in the said bag main body to hang the bag main body, and the said speech part is peelable to the said bag main body so that the use of this hanger engaging part may be prevented. A pharmaceutical bag, which is attached. The medicine bag according to claim 1, wherein the mandatory use portion is provided at a lower portion of the bag body, and is a discharge port for discharging the medicine in the medicine accommodation chamber, and the discharge portion is discharged so as to prevent discharge of the medicine from the discharge port. A medicine bag, wherein the medicine bag is detachably attached to at least a portion of the pot. In the medicine bag of Claim 1, the said essential use part is provided in the lower part of the said bag main body, and is a discharge port for discharging the chemical | medical agent in the said medicine accommodation chamber, and discharge | emission so that the said speech part may prevent discharge of the chemical | medical agent from this discharge port. A pharmaceutical bag provided in a state of covering a port. The medicine bag according to claim 1, wherein the essential use portion is a remaining amount display portion provided on the surface of the bag body to display the remaining amount of the medicine contained in the medicine accommodation chamber, and the compartment is other than the compartment in which the speech portion is shielded from the light shielding portion. A medicine bag, characterized in that configured to conceal at least part of the remaining amount display portion provided in the.